Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV)

Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV)

Item
http://www.wikidata.org/entity/Q28336656
Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosidesAlpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitroIllimaquinone, a selective inhibitor of the RNase H activity of human immunodeficiency virus type 1 reverse transcriptaseThe ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levelsMarked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agentRibavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitroInteraction of 7-hydroxy-8-(phenylazo)1,3-naphthalenedisulfonate with bovine plasma albumin. Spectroscopic studies.Treatment of human immunodeficiency virus infectionsPurinergic receptor functionality is necessary for infection of human hepatocytes by hepatitis delta virus and hepatitis B virus.Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever.Proteoglycans act as cellular hepatitis delta virus attachment receptors.
P2860

Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV)

Item
http://www.wikidata.org/entity/Q28336656
description
1986 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1986
@ast
im März 1986 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 15 March 1986)
@en
vedecký článok (publikovaný 1986/03/15)
@sk
vědecký článek publikovaný v roce 1986
@cs
wetenschappelijk artikel (gepubliceerd op 1986/03/15)
@nl
наукова стаття, опублікована в березні 1986
@uk
научни чланак (објављен 1986/03/15)
@sr
name
Comparative inhibitory effects ...... nopathy-associated virus (LAV)
@ast
Comparative inhibitory effects ...... nopathy-associated virus (LAV)
@en
Comparative inhibitory effects ...... nopathy-associated virus (LAV)
@nl
type
label
Comparative inhibitory effects ...... nopathy-associated virus (LAV)
@ast
Comparative inhibitory effects ...... nopathy-associated virus (LAV)
@en
Comparative inhibitory effects ...... nopathy-associated virus (LAV)
@nl
prefLabel
Comparative inhibitory effects ...... nopathy-associated virus (LAV)
@ast
Comparative inhibitory effects ...... nopathy-associated virus (LAV)
@en
Comparative inhibitory effects ...... nopathy-associated virus (LAV)
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Comparative inhibitory effects ...... nopathy-associated virus (LAV)
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698